NF-κB immunoreactivity is observed in association with βA4 diffuse plaques in patients with Alzheimer's disease

Neuropathology and Applied Neurobiology

Volumn 24, Issue 4, 1998, Pages 271-277

  Ferrer, I ^a,b   Marti E ^b   Lopez E ^a   Tortosa, A ^b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

A4; Alzheimer's disease; Diffuse plaques; NF B; PrP

Indexed keywords

AMYLOID BETA PROTEIN; TRANSCRIPTION FACTOR; ANTIBODY; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; CYTOPLASM; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NERVE CELL; NEURITE; NEUROFIBRILLARY TANGLE; NEUROPIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SENILE PLAQUE; SYNAPSE; SYNAPTOSOME; BRAIN LEVEL; CHEMISTRY; IMMUNOLOGY; METABOLISM; PATHOLOGY; PRION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANTIBODIES; BRAIN CHEMISTRY; CREUTZFELDT-JAKOB SYNDROME; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; NF-KAPPA B; PRIONS; SENILE PLAQUES;

EID: 0031596151     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.1998.00116.x     Document Type: Article

References (29)

1. Baeuerle PA, Baltimore D. NF-kB: ten years after. Cell 1996; 67: 13-20
2. Baeuerle PA, Henkel T. Function and activation of NF-kB in the immune system. Annu Rev Immunol 1994; 12: 141-79
3. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kB. Nature 1995; 376: 167-70
4. Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 1994; 77: 816-27
5. Bugiani O, Giocone G, Verga L, Pollo B, Frangione B, Tagliavini F. Alzheimer patients and Down patients: abnormal presynaplic terminals are related to cerebral preamyloid deposits. Neurosci Lett 1990; 119: 56-9
6. Esiri EM, Hyman BT, Beyreuther K, Masters CL. Ageing and dementia. In Greenfield's Neuropathology. 6th Edn. Vol. 2. Eds DI Graham, PL Lantos. London: Arnold, 1997: 153-233
7. Ferrer I, Martí E, Tortosa A, Blasi J. Dystrophic neurites of senile plaques are defective in proteins involved in exocytosis and neurotransmission. J Neuropathol Exp Neurol 1998; 57: 218-25
8. Ghetti B, Piccardo P, Frangione B et al. Prion protein amyloidosis. Brain Pathol 1996; 6: 127-45
9. Grilli M, Ribola M, Alberici A, Valerio A, Memo A, Spano P. Identification and characterization of a kappa B/Rcl binding site in the regulatory region of the amyloid precursor protein gene. J Biol Chem 1995; 270: 26774-7
10. Guerrini L, Blasi F, Denis-Donini S. Synaptic activation of NF-kB by glutamate in cerebellar granule neurons in vitro. Proc Natl Acad Sci USA 1995; 92: 9077-81
11. Gowing E, Roher AE, Woods AS et al. Chemical characterization of Aβ 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer's disease. J Biol Chem 1994; 269: 10987-90
12. Joachim CL, Morris JH, Selkoe DJ. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. Am J Pathol 1989; 135: 309-19
13. Kaltschmidt B, Uherer M, Volk B, Baeuerle PA, Kalsmichmidt C. Transcription factor NF-kB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci USA 1997; 94: 2462-7
14. Kaltschmidt C, Katschmidt B, Baeuerle PA. Brain synapses contain inducible forms of the transcription factor NF-kB. Mech Dev 1993; 43: 135-47
15. Kaltschmidt C, Kaltschmidt B, Baeuerle PA. Stimulation of ionotropic glutamate receptors activates transcription factor NF-kB in primary neurons. Proc Natl Acad Sci USA 1995; 92: 9618-22
16. Kaltschmidt C, Kaltschmidt B, Neumann H, Wekerle H, Baeuerle PA. Constitutive NF-kB activity in neurons. Mol Cell Biol 1994; 14: 3981-92
17. Kida E, Wisniewski KE, Wisniewski HM. Early amyloid-β deposits show different immunoreactivity to the amino-and carboxyl-terminal regions of β-peptide in Alzheimer's disease and Down's syndrome brain. Neurosci Lett 1995; 193: 105-8
18. Korner M, Rattner A, Mauxion F, Sen R, Citri Y. A brain-specific transcription activator. Neuron 1989; 3: 563-72
19. Masliah E, Terry D, Mallory M, Alford M, Hansen LA. Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. Am J Pathol 1990; 137: 1293-7
20. Meberg PJ, Kinney WR, Valcourt EG, Routtenberg A. Gene expression of the transcription factor NF-kB in hippocampus: regulation by synaptic activity. Mol Brain Res 1996; 38: 179-90
21. Moynagh PN, Williams DC, O'Neill LA. Interleukin-1 activates transcription factor NF-kB in glial cells. Biochem J 1993; 294: 343-7
22. O'Neill LAJ, Kaltschmidt C. NF-kB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 1997; 20: 252-8
23. Probst A, Langui D, Ipsen S, Robakis N, Ulrich J. Deposition of β/A4 protein along neuronal plasma membranes in diffuse senile plaques. Acta Neuropathol 1991; 83: 21-9
24. Rong Y, Baudry M. Seizure activity results in a rapid induction of nuclear factor-kB in adult but not juvenile rat limbic structures. J Neurochem 1996; 67: 662-8
25. Sparacio SM, Zhang Y, Benveniste KN. Cytokine regulation of inlerleukin-6 gene expression in astrocytes involves activation of an NF-kB-like nuclear protein. J Neuroimmunol 1992; 39: 251-42
26. Unlap T, Jope RS. Inhibition of NFkB DNA binding activity by glucocorticoids in rat brain. Neurosci Lett 1995; 198: 41-4
27. Yang K, Mu XS, Hayes RL. Increased cortical nuclear factor-kB (NF-kB) DNA binding activity after traumatic brain injury in rats. Neurosci Lett 1995; 197: 101-104
28. Yamaguchi H, Nakazato Y, Hirai S, Shoji M, Harigaya Y. Electron micrographs of diffuse plaques. Initial stage of senile plaque formation in the Alzheimer brain. Am J Pathol 1989; 135: 593-7
29. Yamaguchi H, Nakazato Y, Hirai S, Shoji M. Immunoelectron microscopic localization of amyloid β protein in the diffuse plaques of the Alzheimer-type dementia. Brain Res 1990; 508: 320-4